ONCT - Oncternal Therapeutics Inc. (ONCT) CEO Jim Breitmeyer on Q1 2021 Results - Earnings Call Transcript
Oncternal Therapeutics, Inc. (ONCT) Q1 2021 Earnings Conference Call May 06, 2021, 05:00 PM ET Company Participants Richard Vincent - Chief Financial Officer Jim Breitmeyer - President & Chief Executive Officer Edwina Baskin-Bey - Acting Chief Medical Officer Conference Call Participants Carl Byrnes - Northland Capital Markets Robert Burns - H.C. Wainwright Kumar Raja - Brookline Capital Market Presentation Operator Good day ladies and gentlemen and welcome to Oncternal's Therapeutics Inc. First Quarter 2021 Financial Results Call. [Operator Instructions] At this time it is my pleasure to turn the floor over to your host Richard Vincent. Sir the floor is yours. Richard Vincent Thank you, Malinda. Good afternoon, everyone, and thank you for joining us today. Joining me on the call this afternoon are our President and CEO, Dr. James Breitmeyer; and our Acting CMO, Dr. Edwina Baskin-Bey. We welcome all of you. Today's call includes a business update and
For further details see:
Oncternal Therapeutics, Inc. (ONCT) CEO Jim Breitmeyer on Q1 2021 Results - Earnings Call Transcript